25 results match your criteria: "Universitair Ziekenhuis (UZ) Brussel[Affiliation]"
Cureus
February 2024
Radiation Oncology, Universitair Ziekenhuis (UZ) Brussel, Brussels, BEL.
Front Oncol
November 2023
Institut du Cancer de Montpellier, Department of Radiation Oncology, Montpellier, France.
Purpose/objectives: An artificial intelligence-based pseudo-CT from low-field MR images is proposed and clinically evaluated to unlock the full potential of MRI-guided adaptive radiotherapy for pelvic cancer care.
Materials And Method: In collaboration with TheraPanacea (TheraPanacea, Paris, France) a pseudo-CT AI-model was generated using end-to-end ensembled self-supervised GANs endowed with cycle consistency using data from 350 pairs of weakly aligned data of pelvis planning CTs and TrueFisp-(0.35T)MRIs.
Front Nutr
September 2023
Erasmus Medisch Centrum -Sophia Kinderziekenhuis, Rotterdam, Netherlands.
Background: Breastfeeding has been positively associated with infant and child neurocognitive development and function. Contributing to this effect may be differences between human milk and infant formula in the milk lipid composition and milk fat globule structure.
Objective: To evaluate the effects of an infant formula mimicking human milk lipid composition and milk fat globule structure on childhood cognitive performance.
Front Nephrol
October 2022
Department of Oncology, Universitair Ziekenhuis (UZ) Brussel - Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Background: Kidney transplant recipients (KTR) are at increased risk of cancer due to chronic immunosuppression. Non-melanoma skin cancer has an excess risk of approximately 250 times higher than the general population. Moreover, in solid organ transplant recipients (SOTR) these cancers have a more aggressive behavior, with an increased risk of metastasis and death.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
June 2023
Centre for Pharmaceutical Research, Research Group of Clinical Pharmacology and Clinical Pharmacy, Vrije Universiteit Brussel, Jette, Belgium.
Direct oral anticoagulants (DOACs) are increasingly used and are an important cornerstone in antithrombotic therapy. Adverse drug reactions (ADRs) such as bleedings have only partially been investigated during clinical trials. The primary goal was to analyse pharmacovigilance data based on spontaneous reports of gastrointestinal (GI) bleedings with DOACs reported to EudraVigilance.
View Article and Find Full Text PDFCancers (Basel)
December 2022
Oncology Center, Universitair Ziekenhuis (UZ) Brussel, 1090 Brussels, Belgium.
Mol Ther
October 2022
Department of Gene Therapy and Regenerative Medicine, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Building D, Room D365, Laarbeeklaan 103, 1090 Brussels, Belgium; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, 3000 Leuven, Belgium. Electronic address:
Allogeneic CD19-specific chimeric antigen receptor (CAR) T cells with inactivated donor T cell receptor (TCR) expression can be used as an "off-the-shelf" therapeutic modality for lymphoid malignancies, thus offering an attractive alternative to autologous, patient-derived T cells. Current approaches for T cell engineering mainly rely on the use of viral vectors. Here, we optimized and validated a non-viral genetic modification platform based on Sleeping Beauty (SB) transposons delivered with minicircles to express CD19-28z.
View Article and Find Full Text PDFMelanoma Res
June 2022
Department of Medical Oncology, Universitair Ziekenhuis (UZ) Brussel, Laarbeeklaan, Brussel.
Immune checkpoint inhibitors (ICI) and targeted therapies form the therapeutic mainstay for v-Raf murine sarcoma viral oncogene homolog B V600-mutated metastatic melanoma. Both treatment regimens can cause inflammatory arthritis. The reported incidence of treatment-induced inflammatory arthritis is low, though presumably underestimated due to lack of awareness, clear definitions and uniform grading systems.
View Article and Find Full Text PDFSci Rep
February 2022
Oncologisch Centrum, Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
Gini's mean difference (GMD, mean absolute difference between any two distinct quantities) of the restricted mean survival times (RMSTs, expectation of life at a given time limit) has been proposed as a new metric where higher GMD indicates better prognostic value. GMD is applied to the RMSTs at 25 years time-horizon to evaluate the long-term overall survival of women with breast cancer who received neoadjuvant chemotherapy, comparing a classification based on the number (pN) versus a classification based on the ratio (LNRc) of positive nodes found at axillary surgery. A total of 233 patients treated in 1980-2009 with documented number of positive nodes (npos) and number of nodes examined (ntot) were identified.
View Article and Find Full Text PDFFront Immunol
February 2022
Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
J Clin Oncol
July 2021
Department of Medicine-Breast Unit, The Royal Marsden NHS Foundation Trust, Breast Cancer Research Division, The Institute of Cancer Research, Surrey, United Kingdom.
Breast
February 2021
ABC Global Alliance, C/o Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address:
People with metastatic breast cancer face many challenges and disparities in obtaining optimal cancer care. These challenges are accentuated in underserved patient populations across Europe, who are less likely to receive quality healthcare for reasons including socioeconomic inequalities, educational or cultural status, or geographic location. While there are many local and national initiatives targeted to address these challenges, there remains a need to reduce disparities and improve access to healthcare to improve outcomes, with a focus on multidisciplinary stakeholder engagement.
View Article and Find Full Text PDFJCO Glob Oncol
November 2020
Feinberg School of Medicine, Northwestern University, Chicago, IL.
Fertility preservation in the cancer setting, known as oncofertility, is a field that requires cross-disciplinary interaction between physicians, basic scientists, clinical researchers, ethicists, lawyers, educators, and religious leaders. Funded by the National Institutes of Health, the Oncofertility Consortium (OC) was formed to be a scientifically grounded, transparent, and altruistic resource, both intellectual and monetary, for building this new field of practice capable of addressing the unique needs of young patients with cancer. The OC has expanded its attention to include other nonmalignant conditions that can threaten fertility, and the work of the OC now extends around the globe, involving partners who together have created a community of shared effort, resources, and practices.
View Article and Find Full Text PDFPatient Educ Couns
January 2021
Vrije Universiteit Brussel, Faculty of Medicine and Pharmacy, Centre for Pharmaceutical Research (CePhar), Brussels, Belgium; Department of Clinical Pharmacology and Pharmacotherapy, Universitair Ziekenhuis (UZ) Brussel, Brussels, Belgium.
Objective: To assess direct oral anticoagulant (DOAC) adherence and to determine possible determinants for suboptimal adherence in Dutch patients with atrial fibrillation (AF).
Methods: Cross-sectional study of DOAC users who completed a self-reported questionnaire. Adherence was measured with Morisky8-item Medication Adherence Scale (MMAS-8).
Hum Reprod Open
February 2020
Center for Reproductive Medicine, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Study Question: Does maturation (IVM) of immature oocytes affect health, including growth at 2 years of age, in singletons born to mothers with polycystic ovary syndrome (PCOS)?
Summary Answer: This study of 92 singletons born after IVM in mothers with PCOS showed no significant differences in anthropometry and health outcome parameters in comparison with a cohort of 74 peers born after intracytoplasmic sperm injection (ICSI) and conventional controlled ovarian stimulation (COS) in mothers with PCOS.
What Is Known Already: IVM has been used worldwide in women with PCOS. However, the paucity of available data related to children's health following IVM is an important impediment to a more widespread use of the technology.
Trials
March 2019
Department of Neurology, Universitair Ziekenhuis (UZ) Brussel, Brussels, Belgium.
Background: Axonal degeneration is related to long-term disability in patients with multiple sclerosis (MS). The underlying mechanism remains ill understood but appears to involve axonal energetic dysfunction. A globally impaired cerebral blood flow (CBF) has been observed in the normal-appearing white matter (NAWM) of patients with MS, which is probably related to astrocytic overexpression of endothelin-1 (ET-1).
View Article and Find Full Text PDFTransl Lung Cancer Res
April 2018
Department of Medical Oncology, Oncology Centre, Universitair Ziekenhuis (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussel, Belgium.
Mol Hum Reprod
May 2017
Research Group Reproduction and Genetics, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, B-1090Brussels, Belgium.
Study Question: Is the spindle assembly checkpoint (SAC) active during human preimplantation development?
Summary Answer: Mitotic spindle disruption during mitosis activates the SAC from at least Day 3 of human preimplantation development, but this does not lead to apoptosis until Day 5.
What Is Known Already: Human preimplantation embryos frequently acquire chromosomal abnormalities, but the mechanisms behind this are poorly understood. It has been speculated that a dysfunctional SAC could be responsible.
Hum Reprod
February 2017
Centre for Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
Study Question: Are reproductive hormone levels (FSH, LH, inhibin B and testosterone) in male offspring conceived by ICSI because of male infertility comparable with those from peers born after spontaneous conception?
Summary Answer: In this cohort of 54 young men conceived by ICSI because of male-factor infertility, mean and median reproductive hormone levels were found to be comparable with results from spontaneously conceived peers, but ICSI-conceived men were more likely to have low inhibin B (<10th percentile) and high FSH (>90th percentile) levels.
What Is Known Already: Since the worldwide oldest ICSI offspring have recently reached young adulthood, their reproductive health can now be investigated. This typically involves semen analysis and a hormonal profiling including the measurement of FSH, LH, inhibin B and testosterone.
Hum Reprod
December 2016
Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
Study Question: What is the semen quality of young adult men who were conceived 18-22 years ago by ICSI for male infertility?
Summary Answer: In this cohort of 54 young adult ICSI men, median sperm concentration, total sperm count and total motile sperm count were significantly lower than in spontaneously conceived peers.
What Is Known Already: The oldest ICSI offspring cohort worldwide has recently reached adulthood. Hence, their reproductive health can now be investigated.
J Glob Oncol
April 2016
Lauren M. Ataman, Brigid M. Smith, Kristin Smith, and Teresa K. Woodruff, Feinberg School of Medicine, Northwestern University, Chicago, IL; Jhenifer K. Rodrigues, Ricardo M. Marinho, João P.J. Caetano, Maurício B. Chehin, Eduardo L. Alves da Motta, Paulo Serafini, Brazilian Oncofertility Consortium; Jhenifer K. Rodrigues, Ricardo M. Marinho, and João P.J. Caetano, Pró-Criar Medicina Reprodutiva; Ricardo M. Marinho and João P.J. Caetano, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte; Maurício B. Chehin, Eduardo L. Alves da Motta, and Paulo Serafini, Huntington Reproductive Medicine and Federal University of São Paulo, São Paulo; João M. de Meneses e Silva, Ceara Blood Center, Centro de Hematologia e Hemoterapia do Ceará, and Assis Chateaubriand Maternity School, Federal University of Ceara; Lígia H.F. Melo e Silva, Federal University of Ceara and Femini Imagem and Ultravida Clinic; Franciele O. Lunardi, State University of Ceara, Fortaleza, Brazil; Nao Suzuki, Seido Takae, and Yodo Sugishita, St Marianna University School of Medicine, Knagawa; Tatsuro Furui and Ken-Ichiro Morishige, Gifu University Graduate School of Medicine, Gifu, Japan; Teresa Almeida-Santos, University Hospital of Coimbra; Teresa Almeida-Santos and Cláudia Melo, University of Coimbra, Coimbra, Portugal; Karen Buzaglo, Clinique Ovo, Montreal, Quebec; Kate Irwin, Cancer Knowledge Network, Milton, Ontario, Canada; W. Hamish Wallace and Roderick T. Mitchell, Edinburgh Royal Hospital for Sick Children; Richard A. Anderson and Roderick T. Mitchell, Queen's Medical Research Institute, University of Edinburgh; Evelyn E. Telfer, Centres for Fertility Preservation and Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom; Satish K. Adiga, Kasturba Medical College, Manipal University, Manipal, India; Antoinette Anazodo and Brigitte Gerstl, Sydney Children's and Prince of Wales Hospital, Future Fertility, Randwick; Elizabeth Sullivan, University of Technology; Richard Cohn, Kids Cancer Centre, Sydney Children's Hospital; Richard Cohn, Rebecca Deans, and William L. Ledger, School of Women's and Children's Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales; Catharyn Stern and Franca Agresta, Royal Women's Hospital, University of Melbourne, Melbourne; Yasmin Jayasinghe and Lisa Orme, Children's Cancer Centre, Royal Children's Hospital, Parkville; Rob McLachlan, Monash Institute of Medical Research, Prince Henry's Institute, Clayton, Victoria; Rebecca L. Robker, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia; Jung R. Lee and Chang S. Suh, Seoul National University Bundang Hospital, Seongnam, and Seoul National University College of Medicine, Seoul, Korea; Michael De Vos, Ellen Van Moer, Dominic Stoop, Veerle Vloeberghs, and Herman Tournaye, Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel; Johan Smitz, Laboratory of Clinical Chemistry and Radioimmunology, UZ Brussel, Brussels, Belgium; Ludwig Wildt and Katharina Winkler-Crepaz, Innsbruck Medical University, Innsbruck, Austria; and Claus Y. Andersen, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark.
Fertility preservation in the cancer setting, known as oncofertility, is a field that requires cross-disciplinary interaction between physicians, basic scientists, clinical researchers, ethicists, lawyers, educators, and religious leaders. Funded by the National Institutes of Health, the Oncofertility Consortium (OC) was formed to be a scientifically grounded, transparent, and altruistic resource, both intellectual and monetary, for building this new field of practice capable of addressing the unique needs of young patients with cancer. The OC has expanded its attention to include other nonmalignant conditions that can threaten fertility, and the work of the OC now extends around the globe, involving partners who together have created a community of shared effort, resources, and practices.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
September 2015
Dermatology, Bern, Im Holenacker 16, CH-3063, Ittigen, Switzerland.
Introduction: Daylight-mediated photodynamic therapy has been shown to be an effective therapy for actinic keratoses (AKs) and a simple and tolerable treatment procedure in three randomized Scandinavian studies and two recent Phase III randomized controlled studies in Australia and Europe.
Objectives: To establish consensus recommendations for the use of daylight photodynamic therapy (DL-PDT) using topical methyl aminolaevulinate (MAL) in European patients with AKs.
Methods: The DL-PDT consensus recommendations were developed on behalf of the European Society for Photodynamic Therapy in Dermatology and comprised of 10 dermatologists from different European countries with experience in how to treat AK patients with PDT.
Cardiovasc Revasc Med
June 2014
Department of Cardiology, Universitair Ziekenhuis (UZ) Brussel, Brussels, Belgium.
We present a new clinically practical method for online co-registration of 3D quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) or optical coherence tomography (OCT). The workflow is based on two modified commercially available software packages. Reconstruction steps are explained and compared to previously available methods.
View Article and Find Full Text PDFCardiovasc Revasc Med
April 2014
Universitair Ziekenhuis (UZ) Brussel, Laarbeeklaan 101, 1090 Brussel, Belgium.
A case is presented in which a breakage of the coronary stent delivery catheter occurred as retrieval of the stent balloon was attempted after stent implantation. The broken distal balloon shaft with its stuck balloon was retrieved by controlled pulling on the guiding catheter in which a new balloon was inflated, thus trapping the distal shaft. The case underscores the importance of adequate lesion assessment and preparation.
View Article and Find Full Text PDFAnn Pharmacother
April 2012
Universitair Ziekenhuis (UZ) Brussel, Department of Clinical Pharmacology and Pharmacotherapy, Jette, Belgium.
Background: Medication discrepancies have the potential to cause harm. Medication reconciliation by clinical pharmacists aims to prevent discrepancies and other drug-related problems.
Objective: To determine how often discrepancies in the physician-acquired medication history result in discrepancies during hospitalization and at discharge.